RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PECCI F
Collezione AO Ordine Mauriziano

Items : 5

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study. in The oncologist / Oncologist. 2022 Sep 2;27(9):e723-e730. doi: 10.1093/oncolo/oyac129.

2022
AO Ordine Mauriziano

Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
AO Ordine Mauriziano

Cortellini A; Giusti R; Filetti M; Citarella F; Adamo V; Santini D; Buti S; Nigro O; Cantini L; Di Maio M; Aerts JGJV; Bria E; Bertolini F; Ferrara MG; Ghidini M; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Mazzoni F; Antonuzzo L; Gelibter A; Marchetti P; Chiari R; Macerelli M; Rastelli F; Della Gravara L; Gori S; et alii...

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406]. in ESMO open / ESMO Open. 2022 Apr;7(2):100471. doi: 10.1016/j.esmoop.2022.100471. Epub 2022 Apr 1.

2022
AO Ordine Mauriziano

Cantini L; Mentrasti G; Lo Russo G; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; La Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; et alii...

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario. in ESMO open / ESMO Open. 2022 Apr;7(2):100406. doi: 10.1016/j.esmoop.2022.100406. Epub 2022 Feb 3.

2022
AO Ordine Mauriziano

Cantini L; Mentrasti G; Russo GL; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; et alii...

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. in Journal of clinical medicine / J Clin Med. 2021 Mar 2;10(5):1005. doi: 10.3390/jcm10051005.

2021
AO Ordine Mauriziano

Lenci E; Cantini L; Pecci F; Cognigni V; Agostinelli V; Mentrasti G; Lupi A; Ranallo N; Paoloni F; Rinaldi S; Nicolardi L; Caglio A; Aerts S; Cortellini A; Ficorella C; Chiari R; Di Maio M; Dingemans AC; Aerts JGJV; Berardi R; Lenci E; Cantini L; Pecci F; Cognigni V; Agostinelli V; Mentrasti G; Lupi A; Ranallo N; Paoloni F; et alii...